CORRECTING and REPLACING Bristol-Myers Squibb to Hold Investor Teleconference to Discuss ASCO Highlights

Please replace the release with the following corrected version due to multiple revisions.

The corrected release reads:

BRISTOL-MYERS SQUIBB TO HOLD INVESTOR TELECONFERENCE TO DISCUSS ASCO HIGHLIGHTS

Bristol-Myers Squibb Company (NYSE:BMY) will host a teleconference on Sunday, June 4, 2017, at 7:30 p.m. EDT (6:30 p.m. CDT) to discuss company strategy and review data presented at the Annual Meeting of the American Society of Clinical Oncology (ASCO) in Chicago. Company executives will provide an overview of company strategy and data presented at the meeting, with a focus on the company’s immuno-oncology portfolio, and address inquiries from investors and analysts.

Investors and the general public are invited to listen to a live webcast of the call at investor.bms.com, by dialing toll free [phone] or international [phone], confirmation code: 3209540. Materials related to the call will be available at the same website prior to the call. A replay of the call will be available beginning at 11:00 p.m. EDT on June 4 through 11:00 p.m. EDT on June 18. The replay can be accessed at investor.bms.com or by dialing [phone] or [phone], confirmation code: 3209540.

About Bristol-Myers Squibb

Bristol-Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. For more information about Bristol-Myers Squibb, visit us at BMS.com or follow us on LinkedIn, Twitter, YouTube and Facebook.

View source version on businesswire.com: http://www.businesswire.com/news/home/20170526005046/en/

Bristol-Myers SquibbMedia:Ken Dominski, [e-mail]:Tim Power, [e-mail] Szablewski, [e-mail]